Clinical Trial Update: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on HTD1801, a Berberine Ursodeoxycholate formulation, for type 2 diabetes mellitus inadequately controlled with metformin, reporti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HTD1801

Snippet

Sponsor: HighTide Biopharma Pty Ltd | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED